ILiAD Biotechnologies, a Weston, FL-based clinical stage biotechnologies company, raised $42.8M in Series D funding.
The round was led by Knott Partners.
The company intends to use the funds to conduct a Phase 2b Human Challenge study to determine if vaccination with BPZE1 prevents colonization from wild-type Bordetella pertussis infection. In addition to funding continued operations, R&D and manufacturing development of BPZE1, the financing will support further clinical studies of the vaccine.
Led by Keith Rubin, MD, Founder and Chief Executive Officer, ILiAD Biotechnologies is a clinical stage biotechnology company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. BPZE1 is the most advanced next generation pertussis vaccine, designed to overcome deficiencies of current vaccines, including limited durability and the inability to prevent nasopharyngeal Bordetella pertussis infections that lead to transmission, especially to vulnerable infants. BPZE1 has completed four human clinical studies and at the end of 2021, the FDA provided BPZE1 with Fast Track designation.
BPZE1 was developed by Camille Locht, PhD and Nathalie Mielcarek, PhD at the Institut Pasteur de Lille and French National Institute of Health and Medical Research. ILiAD holds exclusive global rights to BPZE1 and related B-Tech™ technologies that are covered by 62 issued patents. An additional 31 patents are pending globally.
ILiAD Biotechnologies Closes $42.8M Series D Financing. Congratulations to the entire team. I wish you great success in this endeavour.Shishir Gupta, Founder and CEO, StartupLanes
Don’t keep wondering about funding, you can also raise funds. Learn how to raise funds here: Yes I want to raise funds.
If you are an emerging startup and are looking for investors to raise funds, StartupLanes has its own angel network and investment banking services and is connected to angel investors and VCs in 15 countries that ensure that our member startups have easy access to external funds to scale up constantly.
You can subscribe to our news posts by entering your email in the box on the right side of this page.
Check out our YouTube channel for insightful content from the Indian startup ecosystem.
Or join our Whatsapp group to interact with other founders: Yes, I want to join the Whatsapp group.
The right investment is key to beating inflation and growing your wealth. Do you wish to become an angel investor? Yes, I want to be an angel investor.
Are you a startup and facing challenges in your business? Do you want to grow your business? It is not as difficult as it sounds. Learn how to grow your business here- Yes, I want to grow my business. For any rectifications, reach out to email@example.com